Skip to main content
. 2015 Apr;3(5):70. doi: 10.3978/j.issn.2305-5839.2015.02.13

Table 2. The criteria of an ideal biomarker for clinical use.

Diagnostic biomarkers: c>a>b>e>d>f
Disease activity biomarkers: b>f>a>e>d
Treatment-response biomarkers: f>b>a>e>d

a, a high specificity; b, a reliable sensitivity; c, detectable in AD early; d, inexpensive and user-friendly; e, non-invasive or well-accessible; f, available in monitoring the progression.